Refractory diffuse large B ‐cell lymphoma after first‐line immuno‐CT: Treatment options and outcomes
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - May 3, 2018 Category: Hematology Authors: LaurianeFilliatre ‐clement
,
DelphineMaucort‐Boulch
,
EstelleBourbon
,
LionelKarlin
,
ViolaineSafar
,
EmmanuelBachy
,
PierreSesques
,
EmmanuelleFerrant
,
FadelaBouafia
,
AnneLazareth
,
DanaGhergus
,
BertrandCoiffier
,
Alexandra Source Type: research
Management of newly diagnosed high ‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - April 30, 2018 Category: Hematology Authors: Neil L.Berinstein
,
Nancy M.Pennell
,
RashmiWeerasinghe
,
RenaBuckstein
,
EugeniaPiliotis
,
Kevin R.Imrie
,
LisaChodirker
,
Mary ‐AnneCussen
,
EllenMiles
,
Marciano D.Reis
,
ZeinaGhorab
,
Matthew C.Cheung Source Type: research
Use of depth of response to predict progression ‐free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - April 19, 2018 Category: Hematology Authors: NaveenMangal
,
Ahmed HamedSalem
,
Rajeev M.Menon
,
Kevin J.Freise Source Type: research
Issue Information
Hematological Oncology,Volume 36, Issue 2, Page 379-380, April 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 19, 2018 Category: Hematology Source Type: research
CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5 ‐positive B‐cell neoplasms
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - April 15, 2018 Category: Hematology Authors: CamilleDebord
,
NellyRobillard
,
OlivierTheisen
,
ThomasGastinne
,
PascalGodmer
,
JulieGraveleau
,
StevenLe Gouill
,
OdileLuycx
,
MouradTiab
,
MarionLoirat
,
ElsaLestang
,
SorayaWuill ème
,
CatherineGodon
,
MarionEveillard
,
Source Type: research
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - April 6, 2018 Category: Hematology Authors: NicolaPolverelli
,
Giuseppe A.Palumbo
,
GianniBinotto
,
ElisabettaAbruzzese
,
GiuliaBenevolo
,
MicaelaBergamaschi
,
AlessiaTieghi
,
MassimilianoBonifacio
,
MassimoBreccia
,
LuciaCatani
,
MarioTiribelli
,
MariellaD'Adda
,
NicolaSg Source Type: research
Novel acquisitions on biology and management of transformed follicular lymphoma
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 30, 2018 Category: Hematology Source Type: research
CD200 included in a 4 ‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 30, 2018 Category: Hematology Source Type: research
Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 30, 2018 Category: Hematology Source Type: research
Ruxolitinib for steroid ‐refractory graft‐versus‐host disease: A case series
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 25, 2018 Category: Hematology Source Type: research
Development of novel monoclonal antibodies to dog leukocyte antigen DR displaying direct and immune ‐mediated cytotoxicity toward canine lymphoma cell lines
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 24, 2018 Category: Hematology Source Type: research
---
Hematological Oncology, Ahead of Print. (Source: Hematological Oncology)
Source: Hematological Oncology - March 24, 2018 Category: Hematology Source Type: research
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 7, 2018 Category: Hematology Source Type: research
Atypical chronic myeloid leukaemia: A case of an orphan disease —A multicenter report by the Polish Adult Leukemia Group
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - March 7, 2018 Category: Hematology Source Type: research
---
Hematological Oncology, Ahead of Print. (Source: Hematological Oncology)
Source: Hematological Oncology - March 7, 2018 Category: Hematology Source Type: research
